Literature DB >> 9001197

Prognostic impact of thyroid lymphocytic infiltration in patients with medullary thyroid carcinoma.

L Scopsi1, P Collini, G Sampietro, P Boracchi, S Pilotti.   

Abstract

A retrospective search for lymphocytic infiltration of the thyroid was performed on archival paraffin specimens from 95 cases of thyroid medullary carcinoma observed at a single institution during a 30-year period. A mild lymphocytic infiltration of the nonneoplastic thyroid tissue, mainly concentrated at the edge of the tumor mass, was observed in 33 cases, while in a further 24 cases a moderate to marked lymphocytic infiltration, resembling that seen in chronic lymphocytic thyroiditis, was homogeneously distributed all over the gland, with no apparent relationship to the site of the primary tumor. Virtually no lymphocytic infiltration was detected inside of any of the tumors. The presence of chronic lymphocytic thyroiditis seemed to be a characteristic of the host rather than a tumor-induced event. Statistical univariate analysis of relapse-free survival and overall survival showed that lack of chronic lymphocytic thyroiditis marked those patients with an increased risk of disease recurrence and death. However, the observed risk for survival was statistically nonsignificant, whereas that for disease recurrence was significant and remained in a multivariate model of statistical analysis.

Entities:  

Mesh:

Year:  1996        PMID: 9001197     DOI: 10.1089/thy.1996.6.613

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.

Authors:  G Mazziotti; M Rotondi; G Manganella; R Franco; V Colantuoni; G Amato; C Carella
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

2.  Evidence for antigen presentation to sensitized T cells by thyroid peroxidase (TPO)-specific B cells in mice injected with fibroblasts co-expressing TPO and MHC class II.

Authors:  J Guo; Y Wang; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer.

Authors:  Taofeek K Owonikoko; Mohammad S Hossain; Chandar Bhimani; Zhengjia Chen; Sungjin Kim; Suresh S Ramalingam; Shi-Yong Sun; Dong M Shin; Edmund K Waller; Fadlo R Khuri
Journal:  Cancer       Date:  2013-01-22       Impact factor: 6.860

4.  Concurrent Pheochromocytoma, Paraganglioma, Papillary Thyroid Carcinoma, and Desmoid Tumor: A Case Report with Analyses at the Molecular Level.

Authors:  Lucio Scopsi; Luca Cozzaglio; Paola Collini; Maria Gullo; Italia Bongarzone; Monica Giarola; Paolo Radice; Leandro Gennari
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.